Are you looking for expert advice...

As part of our work to support the prescribing of medical cannabis for children living with treatment-resistant epilepsy, the Medical Cannabis Clinicians Society has developed an expert panel to provide multi-disciplinary guidance to anonymised individual cases presented by prescribing UK physicians.

Led by Professor Mike Barnes, Chair of The Medical Cannabis Clinicians Society, the Resistant Epilepsy Cannabis Assessment Panel (RECAP) is made up of national cannabis experts, all members of the Society’s expert committee. It is supported by international paediatric neurologists with specialisation in the treatment of epilepsy.

Purple ribbon for epilepsy

Objectives of the RECAP Panel

  1. Reduce harm by reducing the impact of unguided care. Some patients are using black market products without clinical oversight, and others are directed to surgery before being given the opportunity to consider medical cannabis.
  2. Support doctors with an independent pathway to procure guidance from their peers with global expertise and clinical experience regarding medical cannabis and epilepsy treatments.
  3. Collect real-world evidence through anonymised data regarding medical cannabis treatment to inform future therapeutic benefit and regulatory procedure.

How the Panel works

  1. The Clinician decides a patient may benefit from medical cannabis treatment and begins to explore options
  2. They contact the Society via email to arrange an appointment with RECAP through Zoom.
  3. The Clinician will complete a short form to provide RECAP with the necessary anonymised information about the patient.
  4. RECAP members will review the case independently, then as a team, before meeting with the prescribing Clinician to discuss the case and provide peer support. This meeting will take place within seven working days of the Clinician’s enquiry, wherever possible.

If you are a paediatrician wishing to prescribe medical cannabis for a patient and need support, email [email protected] to arrange.

News

News, case studies, clinician profiles and patient stories from the Medical Cannabis Clinicians Society.

Patient Stories

Patient Stories

Hear from patients benefiting from medical cannabis treatments in the UK.

Join the MCCS

Join the MCCS

Key reasons to join MCCS, a supportive clinical community growing by the day. Exclusive prescribing information, product details and peer support.

The Primary Care Cannabis Network becomes part of  the Medical Cannabis Clinicians Society 
March 17, 2023

The Primary Care Cannabis Network becomes part of  the Medical Cannabis Clinicians Society 

The Medical Cannabis Clinicians Society is pleased to announce that the Primary Care Cannabis Network (PCCN) has become a part of our Society. This is an important step forward in…

UK CBMP Product Formulary Update
February 20, 2023

UK CBMP Product Formulary Update

The Medical Cannabis Clinicians Society maintains a list of available cannabis-based medical products regularly updated and shared with its members. As a member of the Medical Cannabis Clinicians Society, clinicians…

Knowledge sharing at CT-Cann 2023
February 20, 2023

Knowledge sharing at CT-Cann 2023

The Medical Cannabis Clinicians Society recently endorsed and participated in the 2nd International Congress on Clinical Trials on Cannabis (CT-Cann2023), an education and scientific conference aimed at clinicians and researchers…

MCCS endorse 2nd International Congress on Clinical Trials on Cannabis
November 24, 2022

MCCS endorse 2nd International Congress on Clinical Trials on Cannabis

  The Medical Cannabis Clinicians Society is proud to officially endorse the 2nd International Congress on Clinical Trials on Cannabis, taking place on 15 & 16 February 2023 in London.…